SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    T. Kheradmand, T.L. Anthony, R.C. Harland, G. Testa, J. Hart, J. Renz, H.S. Te, S.R. Marino, Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature, Human Immunology, 2014,

    CrossRef

  2. 2
    Timucin Taner, Mark D. Stegall, Julie K. Heimbach, Antibody-mediated rejection in liver transplantation: Current controversies and future directions, Liver Transplantation, 2014, 20, 4
  3. 3
    Takaaki Koshiba, Hidenori Ohe, Alex G. Bishop, Regenerative Medicine Applications in Organ Transplantation, 2014,

    CrossRef

  4. 4
    Brian D. Tait, Caner Süsal, Howard M. Gebel, Peter W. Nickerson, Andrea A. Zachary, Frans H.J. Claas, Elaine F. Reed, Robert A. Bray, Patricia Campbell, Jeremy R. Chapman, P. Toby Coates, Robert B. Colvin, Emanuele Cozzi, Ilias I.N. Doxiadis, Susan V. Fuggle, John Gill, Denis Glotz, Nils Lachmann, Thalachallour Mohanakumar, Nicole Suciu-Foca, Suchitra Sumitran-Holgersson, Kazunari Tanabe, Craig J. Taylor, Dolly B. Tyan, Angela Webster, Adriana Zeevi, Gerhard Opelz, Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation, Transplantation Journal, 2013, 95, 1, 19

    CrossRef

  5. 5
    H. Kaneku, J. G. O'Leary, N. Banuelos, L. W. Jennings, B. M. Susskind, G. B. Klintmalm, P. I. Terasaki, De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients, American Journal of Transplantation, 2013, 13, 6
  6. 6
    H. Kaneku, J. G. O'Leary, N. Banuelos, L. W. Jennings, B. M. Susskind, G. B. Klintmalm, P. I. Terasaki, De NovoDonor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients, American Journal of Transplantation, 2013, n/a

    CrossRef

  7. 7
    A. Kressel, G. Therapondos, H. Bohorquez, B. Borg, D. Bruce, I. Carmody, A. Cohen, N. Girgrah, S. Joshi, T. Reichman, G. E. Loss, Excellent liver retransplantation outcomes in hepatitis C-infected recipients, Clinical Transplantation, 2013, 27, 4
  8. 8
    Jacqueline G. O’Leary, Göran B. Klintmalm, Impact of donor-specific antibodies on results of liver transplantation, Current Opinion in Organ Transplantation, 2013, 18, 3, 279

    CrossRef

  9. 9
    Kayo Waki, Yasuhiko Sugawara, Koichi Mizuta, Michiko Taniguchi, Miyuki Ozawa, Masaru Hirata, Masumi Nozawa, Junichi Kaneko, Koki Takahashi, Takashi Kadowaki, Paul I. Terasaki, Norihiro Kokudo, Predicting Operational Tolerance in Pediatric Living-Donor Liver Transplantation by Absence of HLA Antibodies, Transplantation Journal, 2013, 95, 1, 177

    CrossRef

  10. 10
    Jacqueline G. O'Leary, Hugo Kaneku, Linda W. Jennings, Nubia Bañuelos, Brian M. Susskind, Paul I. Terasaki, Göran B. Klintmalm, Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation, Liver Transplantation, 2013, 19, 9
  11. 11
    Milljae Shin, Hyung Hwan Moon, Jong Man Kim, Jae Berm Park, Choon Hyuck David Kwon, Sung-Joo Kim, Suk-Koo Lee, Jae-Won Joh, Significance of True-Positive and False-Positive Pretransplantation Lymphocytotoxic Crossmatch in Primary Liver Allograft Outcomes, Transplantation Journal, 2013, 95, 11, 1410

    CrossRef

  12. 12
    M. H. Ravindranath, T. Pham, M. Ozawa, P. I. Terasaki, Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients, International Immunology, 2012, 24, 1, 43

    CrossRef

  13. 13
    Aya Miyagawa-Hayashino, Atushi Yoshizawa, Yoichiro Uchida, Hiroto Egawa, Kimiko Yurugi, Satohiro Masuda, Sachiko Minamiguchi, Taira Maekawa, Shinji Uemoto, Hironori Haga, Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts, Liver Transplantation, 2012, 18, 11
  14. 14
    J. G. O’Leary, H. Kaneku, B. M. Susskind, L. W. Jennings, M. A. Neri, G. L. Davis, G. B. Klintmalm, P. I. Terasaki, High Mean Fluorescence Intensity Donor-Specific Anti-HLA Antibodies Associated With Chronic Rejection Postliver Transplant, American Journal of Transplantation, 2011, 11, 9
  15. 15
    Tomasz Kozlowski, Tara Rubinas, Volker Nickeleit, John Woosley, John Schmitz, Dana Collins, Paul Hayashi, Anthony Passannante, Kenneth Andreoni, Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies, Liver Transplantation, 2011, 17, 4
  16. 16
    A. I. Musat, R. M. Agni, P. Y. Wai, J. D. Pirsch, D. F. Lorentzen, A. Powell, G. E. Leverson, J. M. Bellingham, L. A. Fernandez, D. P. Foley, J. D. Mezrich, A. M. D’Alessandro, M. R. Lucey, The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation, American Journal of Transplantation, 2011, 11, 3